What are the characteristics of EMEIS stock?

EMEIS is a company operating in the Santé · Etablissements de santé / EHPAD sector. The stock is listed on Euronext Paris under ISIN FR001400NLM4.

What is the recent price evolution of EMEIS stock?

Since last close: 0.71 %. Over one week: 2.52 %. Over one year: 39.97 %.

EMEIS: +8.64% at Opening, Refinancing Revitalizes Momentum

EMEIS shares are experiencing a significant upward trend, driven by a principle refinancing agreement announced on November 10, 2025, which has reinvigorated the stock.

Published on Nov 10, 2025 at 10:06

EMEIS

14.26 € +0.71 %

Technical Indicators Highlight Promising Setup

Technical indicators reveal an interesting configuration. The 50-day moving average at €13.40 confirms a positive underlying trend, while the RSI at 39 suggests a potential for a technical rebound following a consolidation phase.

Contained Volatility and Negative Beta Suggest Stability

Free · Every morning

Technical market signals, before the opening bell.

Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.

✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis

Indicative data. No investment advice. Unsubscribe at any time.

The contained volatility at 14.64% and a negative beta of -0.08 indicate relative stability. The buy signal from the Stochastic Oscillator supports a bullish momentum, with solid technical support at €12.84 and a resistance level to overcome at €15.71.

🏢 Other stocks — Santé

🗞️ MedInCell Stock Tests Key Technical Threshold Despite +60% Yearly Gain 🗞️ Clariane Shares Surge Over 5%, Crossing 4 Euros in Defiance of CAC 40 🗞️ BioMérieux Shares Hit Seven-Year Low After Disappointing Quarter 🗞️ Clariane: Organic Growth of 4.9% in the First Quarter

Context

Period

Period: 9M 2025

Guidance from the release

Croissance organique soutenue (+6,4% à fin septembre 2025, +7,0% au T3), amélioration notable des taux d'occupation, objectifs de cessions dépassés (2,1 Md€) et confirmation des perspectives 2025 et de la trajectoire 2024-2028.

Risks mentioned

Risques et incertitudes liés aux conditions de marché futures pouvant affecter les résultats prévisionnels
Risque de non-réalisation ou de délai des cessions actuellement sécurisées ou en négociation
Impact transitoire des ouvertures récentes sur les taux d'occupation dans certaines zones

Opportunities identified

Croissance démographique des plus de 75 ans (+30% d'ici 10 ans) créant une demande structurelle accrue
Déficit structurel d'offre (déficit attendu de lits sur principaux marchés) offrant une forte visibilité commerciale
Possibilités de capture d'effets prix favorables et d'amélioration de marges opérationnelles

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Technical Indicators Highlight Promising Setup

Contained Volatility and Negative Beta Suggest Stability

Context

Also read